Brief: Immuron Says U.S. FDA Removed Clinical Hold On New Campylobacter ETEC Therapeutic IND Application
May 8 (Reuters) - Immuron Ltd IMC.AX :
* U.S. FOOD AND DRUG ADMINISTRATION REMOVED CLINICAL HOLD ON
NEW
CAMPYLOBACTER ETEC THERAPEUTIC IND APPLICATION
Source text for Eikon: ID:nASX3tgb9n
Further company coverage: IMC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Immuron
See all newsBrief: Immuron Engages LifeSci Capital as its Exclusive Financial Advisor to Explore Strategic Initiatives
Australia's Immuron hits near 1.5-month high on distribution deal in US
Brief: Immuron Executes Exclusive Distribution Agreement For Proibs In The United States
Brief: Immuron Reports FY26 Preliminary Results
Brief: Immuron Posts FY Revenue From Ordinary Activities Of A$7.71 Million